scholarly journals Closure of bronchopleural fistula by a septal occluder device: a case for close collaboration between heart and lung specialists

2019 ◽  
Vol 12 (7) ◽  
pp. e229575
Author(s):  
Célia Marques Domingues ◽  
Vitor Matos ◽  
António Ferreira ◽  
Elisabete Jorge ◽  
João Bernardo ◽  
...  
Keyword(s):  
Surgical Intervention ◽  
Bronchopleural Fistula ◽  
Hybrid Procedure ◽  
Close Collaboration ◽  
Complete Occlusion ◽  
Hybrid Techniques ◽  
Septal Occluder Device ◽  
Occluder Device ◽  
Biologic Glue

We present the case of a 66-year-old woman who underwent right inferior lobectomy for pulmonary carcinoma and developed persistent bronchopleural fistula (BPF) that was not amenable to surgical intervention (two surgical failures). The patient presented with a persistent cough and dyspnoea, which was treated with a hybrid procedure using fluoroscopy and bronchoscopy. A 7 mm Amplatzer septal occluder device (ASOD) was successfully inserted into the BPF. Two weeks after the procedure, a small fistula developed, which was treated by endoscopically guided biologic glue embolisation. At 2-month, 6-month and 12-month follow-up visits, clinical examinations and endoscopic imaging confirmed the complete occlusion of the BPF. Obvious migration of the ASOD was not apparent, and the patient has remained asymptomatic. The success of an endoscopic BPF closure with the use of hybrid techniques was achieved because of a collaborative effort by a multidisciplinary team.

Endovascular Repair of an Ascending Aortic Pseudoaneurysm With a Septal Occluder Device: Mid-Term Follow-Up

2008 ◽  
Vol 85 (1) ◽  
pp. 349-351 ◽  
Author(s):  
Jacques Kpodonu ◽  
Grayson H. Wheatley ◽  
Venkatesh G. Ramaiah ◽  
Julio A. Rodriguez-Lopez ◽  
Robert K. Strumpf ◽  
...  
Keyword(s):  
Endovascular Repair ◽  
Aortic Pseudoaneurysm ◽  
Septal Occluder Device ◽  
Occluder Device ◽  
Ascending Aortic Pseudoaneurysm

Closure of Chronic Bronchopleural Fistula Using Atrial Septal Occluder Device

2014 ◽  
Vol 21 (1) ◽  
pp. 82-84 ◽  
Author(s):  
Vikas Marwah ◽  
Ashok Kumar Rajput ◽  
Heman Madan ◽  
Yadvir Garg
Keyword(s):  
Bronchopleural Fistula ◽  
Septal Occluder Device ◽  
Occluder Device

Early clinical experience with use of the ‘Amplatzer Septal Occluder’ device for atrial septal defect

1998 ◽  
Vol 8 (3) ◽  
pp. 295-302 ◽  
Author(s):  
James L Wilkinson ◽  
Tiow Hoe Goh
Keyword(s):  
Atrial Septal Defect ◽  
Septal Defect ◽  
Amplatzer Septal Occluder ◽  
Device Closure ◽  
Multiple Defects ◽  
Complete Closure ◽  
Septal Occluder Device ◽  
Occluder Device ◽  
The Right

AbstractDevice closure of oval fossa atrial scptal defects with the Amplatzer Septal Occluder was performed in 26 patients ranging in age from 0.89 to 60.44 years. In eight additional patients no device implant was performed because of the presence of multiple defects or because the defect was of a size unsuitable for closure with the devices currently available. The strectched diameter of the defects that were closed ranged from 4 to 23 mm (mean 14±5.4 mm) and device sizes ranged from 4 to 24 mm. Two devices were unstable, of which one embolized to the right atrium after release. Both devices were retrived at the same procedure. One of these parients subsequently underwent a successful device closure of his defect using a larger (24-mm) device. Three patients had multiple defects, which were successfully closed with a single device. At 1-month follow-up 23/26 (88%) and at 3-month follow-up 22/24 (92%) patients had complete closure of their defects, while two had residual shunts. One further patient who had complete closure of his defect at 1-month post-implant had his device removed and his atrial septal defect patched surgically 8 weeks after device closure. This was done as a result of the development of a vegetation affecting the device after an episode of septicaemia, which was not relate to the cardiac problems. There was no procedure-related morbidty or martality and all patients remain well at the present time.

scholarly journals Late embolisation of an atrial septal occluder device in the abdominal aorta

2020 ◽  
Vol 2020 (3) ◽  
Author(s):  
Emre Özdemir ◽  
Cem Nazlı
Keyword(s):  
Abdominal Aorta ◽  
Septal Defect ◽  
Adult Congenital Heart Disease ◽  
Late Complications ◽  
Percutaneous Closure ◽  
Secundum Atrial Septal Defect ◽  
Septal Occluder Device ◽  
Adult Congenital ◽  
Occluder Device

Percutaneous closure of secundum atrial septal defect (sASD) - which is the most common in adult congenital heart disease - is considered to be the first treatment option but can involve early and late complications. We report on the late embolization of a device to the abdominal aorta, 12 months after successful percutaneous closure of sASD. A 63-year-old woman, who suffered from stomach ache, was found to have an ASD occluder device in her abdominal aorta.Although surgical intervention to remove the embolisation may be considered, medical follow-up and re-intervention of percutaneous closure may be feasible for inappropriate cases.

scholarly journals Very late (>5 years) thrombus formation on an atrial septal defect device: a case report

2020 ◽  
Vol 8 (11) ◽  
pp. 4149
Author(s):  
Sudheer Venkata Bolinera ◽  
Srinivas Soma ◽  
Sanivarapu Srinivasa Reddy ◽  
Vijaya Pamidimukkala ◽  
Michael Naronha ◽  
...  
Keyword(s):  
Atrial Septal Defect ◽  
Septal Defect ◽  
Thrombus Formation ◽  
Device Closure ◽  
Atrial Septal Defect Closure ◽  
Septal Occluder Device ◽  
Occluder Device ◽  
History Of

Though percutaneous transcatheter atrial septal defect closure with newer generation occluder devices is a standard treatment at present, these devices have significant long-term risks (>1 year) associated with such as thrombus formation. Here, we present a case of 28 year-old patient presented with few symptoms and had a history of ASD device closure using amplatzer septal occluder device five years back. The patient was found to have a large thrombus (30×33 mm) attached to the device which was managed using anticoagulants and patients was advised for regular echocardiographic follow-up.

Incomplete endothelialisation of an Amplatzer Septal Occluder device followed by meningitis and late acute bacterial endocarditis

2015 ◽  
Vol 26 (4) ◽  
pp. 808-810 ◽  
Author(s):  
Jacek Białkowski ◽  
Szymon Pawlak ◽  
Paweł Banaszak
Keyword(s):  
Present Report ◽  
Wire Mesh ◽  
Amplatzer Septal Occluder ◽  
Nitinol Wire ◽  
Septal Occluder Device ◽  
Long Term Follow Up ◽  
Occluder Device ◽  
History Of

AbstractA 19-year-old woman with atrial septal defect treated percutaneously with an Amplatzer Septal Occluder 24 months earlier, who presented with a history of bacterial meningitis, was admitted with a diagnosis of endocarditis. After 6 weeks of treatment with antibiotics, the incompletely endothelialised occluder was surgically removed. The present report illustrates the need for long-term follow-up of patients who have received nitinol wire mesh occluders.

Effectiveness of the Chiari Health Index for Pediatrics instrument in measuring postoperative health-related quality of life in pediatric patients with Chiari malformation type I

2020 ◽  
pp. 1-6
Author(s):  
Georgina E. Sellyn ◽  
Alan R. Tang ◽  
Shilin Zhao ◽  
Madeleine Sherburn ◽  
Rachel Pellegrino ◽  
...  
Keyword(s):  
Surgical Intervention ◽  
Type I ◽  
Health Related Quality ◽  
Health Index ◽  
Chiari Malformation Type I ◽  
Related Quality ◽  
Health Related ◽  
Over Time

OBJECTIVEThe authors’ previously published work validated the Chiari Health Index for Pediatrics (CHIP), a new instrument for measuring health-related quality of life (HRQOL) for pediatric Chiari malformation type I (CM-I) patients. In this study, the authors further evaluated the CHIP to assess HRQOL changes over time and correlate changes in HRQOL to changes in symptomatology and radiological factors in CM-I patients who undergo surgical intervention. Strong HRQOL evaluation instruments are currently lacking for pediatric CM-I patients, creating the need for a standardized HRQOL instrument for this patient population. This study serves as the first analysis of the CHIP instrument’s effectiveness in measuring short-term HRQOL changes in pediatric CM-I patients and can be a useful tool in future CM-I HRQOL studies.METHODSThe authors evaluated prospectively collected CHIP scores and clinical factors of surgical intervention in patients younger than 18 years. To be included, patients completed a baseline CHIP captured during the preoperative visit, and at least 1 follow-up CHIP administered postoperatively. CHIP has 2 domains (physical and psychosocial) comprising 4 components, the 3 physical components of pain frequency, pain severity, and nonpain symptoms, and a single psychosocial component. Each CHIP category is scored on a scale, with 0 indicating absent and 1 indicating present, with higher scores indicating better HRQOL. Wilcoxon paired tests, Spearman correlations, and linear regression models were used to evaluate and correlate HRQOL, symptomatology, and radiographic factors.RESULTSSixty-three patients made up the analysis cohort (92% Caucasian, 52% female, mean age 11.8 years, average follow-up time 15.4 months). Dural augmentation was performed in 92% of patients. Of the 63 patients, 48 reported preoperative symptoms and 42 had a preoperative syrinx. From baseline, overall CHIP scores significantly improved over time (from 0.71 to 0.78, p < 0.001). Significant improvement in CHIP scores was seen in patients presenting at baseline with neck/back pain (p = 0.015) and headaches (p < 0.001) and in patients with extremity numbness trending at p = 0.064. Patients with syringomyelia were found to have improvement in CHIP scores over time (0.75 to 0.82, p < 0.001), as well as significant improvement in all 4 components. Additionally, improved CHIP scores were found to be significantly associated with age in patients with cervical (p = 0.009) or thoracic (p = 0.011) syrinxes.CONCLUSIONSThe study data show that the CHIP is an effective instrument for measuring HRQOL over time. Additionally, the CHIP was found to be significantly correlated to changes in symptomatology, a finding indicating that this instrument is a clinically valuable tool for the management of CM-I.

Factors related to complete occlusion of arteriovenous malformations after gamma knife radiosurgery

2000 ◽  
Vol 93 (supplement_3) ◽  
pp. 96-101 ◽  
Author(s):  
Jong Hee Chang ◽  
Jin Woo Chang ◽  
Yong Gou Park ◽  
Sang Sup Chung
Keyword(s):  
Gamma Knife ◽  
Arteriovenous Malformations ◽  
Gamma Knife Radiosurgery ◽  
Maximum Diameter ◽  
Content Type ◽  
Complete Occlusion ◽  
Factors Associated ◽  
Martin Grade ◽  
Fine Print

Object. The authors sought to evaluate the effects of gamma knife radiosurgery (GKS) on cerebral arteriovenous malformations (AVMs) and the factors associated with complete occlusion. Methods. A total of 301 radiosurgical procedures for 277 cerebral AVMs were performed between December 1988 and December 1999. Two hundred seventy-eight lesions in 254 patients who were treated with GKS from May 1992 to December 1999 were analyzed. Several clinical and radiological parameters were evaluated. Conclusions. The total obliteration rate for the cases with an adequate radiological follow up of more than 2 years was 78.9%. In multivariate analysis, maximum diameter, angiographically delineated shape of the AVM nidus, and the number of draining veins significantly influenced the result of radiosurgery. In addition, margin radiation dose, Spetzler—Martin grade, and the flow pattern of the AVM nidus also had some influence on the outcome. In addition to the size, topography, and radiosurgical parameters of AVMs, it would seem to be necessary to consider the angioarchitectural and hemodynamic aspects to select proper candidates for radiosurgery.

Sign in / Sign up

Export Citation Format

Share Document